- Conditions
- Influenza, Human
- Interventions
- bioCSL Trivalent Influenza Virus Vaccine (CSL TIV), Comparator Quadrivalent Influenza Virus Vaccine
- Biological
- Lead sponsor
- Seqirus
- Industry
- Eligibility
- 5 Years to 8 Years
- Enrollment
- 402 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2014
- U.S. locations
- 11
- States / cities
- Los Angeles, California • Boise, Idaho • St Louis, Missouri + 8 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–34
of 10
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Influenza
- Interventions
- Fluarix, Fluzone
- Biological
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 6 Months to 35 Months
- Enrollment
- 3,317 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2009
- U.S. locations
- 62
- States / cities
- Birmingham, Alabama • Dothan, Alabama • Benton, Arkansas + 58 more
- Conditions
- Prevention of Meningococcal Disease
- Interventions
- MenACWY-CRM Vaccine, MenACWY-PS Vaccine
- Biological
- Lead sponsor
- Novartis Vaccines
- Industry
- Eligibility
- 12 Months to 10 Years
- Enrollment
- 910 participants
- Timeline
- 2005 – 2006
- U.S. locations
- 1
- States / cities
- Oakland, California
- Conditions
- Autism Spectrum Disorder, Sleep Disturbance
- Interventions
- Sleep Parent Training, Sleep Parent Education
- Behavioral
- Lead sponsor
- The Cleveland Clinic
- Other
- Eligibility
- 2 Years to 7 Years
- Enrollment
- 91 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2022
- U.S. locations
- 1
- States / cities
- Cleveland, Ohio
- Conditions
- Influenza
- Interventions
- DCVC H1 HA mRNA vaccine, Quadrivalent Recombinant Seasonal Influenza Vaccine, Sodium Chloride, 0.9%
- Biological · Other
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years to 49 Years
- Enrollment
- 50 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2026
- U.S. locations
- 1
- States / cities
- Iowa City, Iowa
- Conditions
- Pneumococcal Disease
- Interventions
- Multivalent Pneumococcal Vaccine - Formulation 1, Multivalent Pneumococcal Vaccine - Formulation 2, 20-valent pneumococcal conjugate vaccine (20vPnC), Licensed pneumococcal comparator vaccine, Multivalent Pneumococcal Vaccine - Formulation 3, Multivalent Pneumococcal Vaccine - Formulation 4
- Biological
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1,363 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2026
- U.S. locations
- 20
- States / cities
- Doral, Florida • Hialeah, Florida • Stockbridge, Georgia + 13 more
- Conditions
- Meningococcal Meningitis
- Interventions
- MenACWY-CRM conjugate vaccine, Licensed comparator
- Biological
- Lead sponsor
- Novartis Vaccines
- Industry
- Eligibility
- 11 Years to 18 Years
- Enrollment
- 389 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009 – 2012
- U.S. locations
- 32
- States / cities
- Birmingham, Alabama • Fremont, California • Fresno, California + 21 more
- Conditions
- Tooth Sensitivity
- Interventions
- Prof applied oxalate, Self applied oxalate, Prof applied placebo
- Device
- Lead sponsor
- University of Minnesota
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 60 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2015 – 2016
- U.S. locations
- 1
- States / cities
- Minneapolis, Minnesota
- Conditions
- Depressive Symptoms
- Interventions
- Resiliency Class, Resource for Services (RS)
- Behavioral · Other
- Lead sponsor
- Bowen Chung, MD, MSHS
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 265 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2019
- U.S. locations
- 22
- States / cities
- Compton, California • Long Beach, California • Los Angeles, California + 1 more
- Conditions
- Seasonal Influenza
- Interventions
- mRNA-1010, Fluarix®, Influsplit® Tetra, Fluarix Tetra, Alpharix® Tetra
- Biological
- Lead sponsor
- ModernaTX, Inc.
- Industry
- Eligibility
- 50 Years and older
- Enrollment
- 40,805 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2025
- U.S. locations
- 188
- States / cities
- Anniston, Alabama • Athens, Alabama • Birmingham, Alabama + 150 more